Cost-effectiveness of low-dose CT screening for non-smokers with a first-degree relative history of lung cancer

BMC Public Health

Table 2 Base-case cost-effectiveness results compared among different strategies in 100,000 individuals over the lifetime

Strategy	Cost (CNY, thousand)	QALYs	Incremental Cost (CNY, thousand)		Incremental QALYs		ICER (CNY/QALY)
Strategy	Cost (CNY, thousand)	QALYs	Vs No screening	Vs the strategy preceding it on the efficiency frontier	Vs No screening	Vs the strategy preceding it on the efficiency frontier	Vs No screening	Vs the strategy preceding it on the efficiency frontier
No screening	47,172	1,346,222	-	-	-	-	-	-
50_one-off	74,180	1,346,235	27,008	27,008	13	13	Dominated	Dominated
55_one-off	69,844	1,346,406	22,672	22,672	184	184	123,770	123,770
60_one-off	64,801	1,346,505	17,629	17,629	283	283	62,381	62,381
65_one-off^a	60,305	1,346,508	13,133	13,133	286	286	45,934	45,934
65_triennial^a	76,034	1,346,826	28,862	15,729	604	318	47,850	49,576
65_biennial	90,284	1,346,988	43,112	14,250	766	162	56,322	87,816
65_annual	133,424	1,347,261	86,252	57,390	1,039	435	83,024	131,721
60_triennial^a	107,935	1,347,344	60,763	31,901	1,122	518	54,183	61,554
50_triennial	191,588	1,347,608	144,416	83,653	1,386	264	104,251	Dominated
55_triennial	139,067	1,347,617	91,895	31,132	1,395	273	65,904	114,062
60_biennial^a	135,850	1,347,652	88,678	27,915	1,430	308	62,046	90,692
60_annual	206,314	1,347,891	159,142	70,464	1,669	239	95,397	Dominated
50_annual	429,412	1,347,963	382,240	293,562	1,741	311	219,584	Dominated
55_biennial^a	175,816	1,347,973	128,644	39,966	1,751	321	73,471	124,230
50_biennial	252,412	1,347,976	205,240	76,596	1,754	3	117,031	Dominated
55_annual^a	303,528	1,348,238	256,356	127,712	2,016	265	127,210	Dominated

ISSN: 1471-2458